Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Eli Lilly & Co ( (LLY) ) is now available.
Eli Lilly and Company announced the appointment of Jon Moeller, Chairman and CEO of Procter & Gamble, to its board of directors, effective December 1, 2024. Moeller brings extensive experience in leadership and strategic operations, complementing Lilly’s focus on innovation and growth. Concurrently, board member Karen Walker will resign at the end of 2024 but will continue collaborating with Lilly on digital initiatives in 2025. This transition marks a strategic evolution for Lilly as it enhances its digital and commercial capabilities.
For detailed information about LLY stock, go to TipRanks’ Stock Analysis page.